Author:
Jang Sae K,Berlacher Kathryn,Hauspurg Alisse
Abstract
Abstract
Background
Methylergonovine is a vasoconstrictive agent historically used as a provocative agent in the lab for coronary vasospasm; it is also a first line uterotonic agent for management of postpartum hemorrhage.
Case Presentation
A 29-year-old female with history of smoking and idiopathic thrombocytopenia received intramuscular methylergonovine after delivery of twins for intrauterine hemorrhage management. Subsequently, she had episodes of chest pain with high sensitivity Troponin I elevation to 1509 ng/L with accompanying septal T wave inversions, decreased left ventricular ejection fraction to 49% and basal septal wall hypokinesis. Computed tomography (CT) coronary angiogram showed patent coronary arteries and no coronary arterial dissection. The patient was conservatively managed with aspirin and metoprolol, and on follow up had fully recovered left ventricular function with resolution of wall motion abnormalities. Given this, coronary vasospasm due to intramuscular methylergonovine is the most likely cause of patient’s chest pain and associated myocardial ischemia.
Conclusions
Intramuscular, intrauterine, intravenous, and even oral methylergonovine can rarely cause coronary vasospasm leading to myocardial ischemia. Cardiologists caring for postpartum patients should be aware of these potential lethal complications; prompt identification and administration of sublingual nitroglycerin can prevent severe complications of arrythmias, heart block, or cardiac arrest.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference8 articles.
1. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 1982 Jun;65(7):1299 – 306. doi: https://doi.org/10.1161/01.cir.65.7.1299. PMID: 7200405.
2. Bory M, Joly P, Bonnet JL, Djiane P, Serradimigni A. Methergin testing with angiographically normal coronary arteries. Am J Cardiol. 1988 Feb 1;61(4):298–302. doi: https://doi.org/10.1016/0002-9149(88)90934-4. PMID: 3341205.
3. Frantz RP, Lerman A, Edwards BS, Olson LJ, Higano ST, Schwartz RS, Daly RC, McGregor CG, Rodeheffer RJ. Methylergonovine-induced diffuse coronary spasm in a patient with exercise-induced coronary spasm after heart transplantation. J Heart Lung Transplant. 1994 Sep-Oct;13(5):834–9. PMID: 7803424.
4. Lin YH, Seow KM, Hwang JL, Chen HH. Myocardial infarction and mortality caused by methylergonovine. Acta Obstet Gynecol Scand. 2005 Oct;84(10):1022. doi: https://doi.org/10.1111/j.0001-6349.2005.0058d.x. PMID: 16167925.
5. Kuczkowski KM. Myocardial ischemia induced by intramyometrial injection of methylergonovine maleate. Anesthesiology. 2004 Apr;100(4):1043. doi: https://doi.org/10.1097/00000542-200404000-00055. PMID: 15087660.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献